The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Network meta-analysis (NMA) of immuno-oncology (IO) monotherapy as first-line (1L) treatments (txs) for advanced non-small cell lung cancer (NSCLC) with PD-L1 expression ≥50%.
 
Nicholas Freemantle
Consulting or Advisory Role - ALK; Allergan; AstraZeneca; Ipsen; Novo Nordisk; Regeneron; Sanofi; Vertex
Speakers' Bureau - Sanofi
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - ALK; Allergan; AstraZeneca; Ipsen; Novo Nordisk; Sanofi; Vertex
 
Yingxin Xu
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Florence Wilson
Employment - Precision HEOR
Research Funding - Regeneron (Inst)
 
Patricia Guyot
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Research Funding - Sanofi
 
Chieh-I Chen
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Sam Keeping
Employment - PRECISIONHeor
 
Gerasimos Konidaris
Employment - Sanofi
 
Keith Chan
Employment - Precision HEOR
Research Funding - Bristol-Myers Squibb; Kite, a Gilead Company; Novartis; Regeneron; Sanofi; Takeda
 
Andreas Kuznik
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Kokuvi Atsou
Employment - Sanofi/Aventis
Stock and Other Ownership Interests - Sanofi/Aventis
Travel, Accommodations, Expenses - Sanofi/Aventis
 
Emily Glowienka
Employment - Precision HEOR
Research Funding - Regeneron (Inst)
 
Lisa Stow
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Jean-Francois Pouliot
No Relationships to Disclose
 
Giuseppe Gullo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Petra Rietschel
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Naiyer A. Rizvi
Stock and Other Ownership Interests - Arcus Biosciences; Bellicum Pharmaceuticals; Brooklyn ImmunoTherapeutics; Gritstone Bio
Consulting or Advisory Role - Abbvie; Abbvie; Apricity Health; Arcus Biosciences; AstraZeneca/MedImmune; Bellicum Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Editas Medicine; EMD Serono; Genentech/Roche; GlaxoSmithKline; Illumina; Janssen; Lilly; Merck Sharp & Dohme; NeoGenomics Laboratories; Novartis; Regeneron; Takeda
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - Royalties related to patent filed by MSKCC, Determinants of cancer response to immunotherapy (PCT/US2015/062208) licensed to Personal Genome Diagnostics